Borealis is a Canada-based biotechnology company that researches and develops novel xRNA-based medicines for the treatment of kidney diseases.
$150M
Aug 21, 2024
-
Voyager is a Massachusetts-based biotechnology company that researches and develops genetic medicines for the treatment of neurological diseases.
$20M
Jan 02, 2024
-
Flare Therapeutics is a Massachusetts-based biotechnology company that researches and develops precision medicines for the treatment of cancer.
$123M
Mar 21, 2023
-
Holmusk is a New York-based digital health platform that provides solutions such as AI-powered behavioral health analytics and EHR for the healthcare industry.
$45M
Jan 08, 2023
-
Alto is a California-based biopharmaceutical company that researches and develops novel precision medicines for patients with neuropsychiatric disorders.
$35M
Oct 24, 2022
-
Frequently Asked Questions about Novartis
What is Novartis investing in?
Novartis has invested in 63 companies including Borealis, Voyager and Flare Therapeutics
What company did Novartis invest in?
Novartis invested in a total 63 companies including Borealis, Voyager and Flare Therapeutics
What are the top 5 investments by Novartis?
The top companies in which Novartis invested are Borealis, Voyager, Flare Therapeutics, Holmusk and Alto
